828 results on '"Reiser J"'
Search Results
102. Enhancing the DEMO divertor target by interlayer engineering
103. Neutron diffraction stress determination in W-laminates for structural divertor applications
104. Lupus nephritis: through the looking-glass
105. Fracture behavior of tungsten materials and the impact on the divertor design in nuclear fusion power plants
106. Tungsten materials for structural divertor applications
107. Registration of common bacterial blight resistant pinto bean germplasm line ABCP-8
108. Simulation of an 1857-like Mw 7.9 San Andreas fault earthquake and the response of tall steel moment frame buildings in southern California -A prototype study
109. CRYPTIC SPLICE SITES IN THE RABBIT ß-GLOBIN GENE ARE REVEALED FOLLOWING INACTIVATION OF AN AUTHENTIC 5′ SPLICE SITE BY MUTAGENESIS IN VITRO
110. EXPRESSION OF β-GLOBIN GENES MODIFIED BY RESTRUCTURING AND SITE-DIRECTED MUTAGENESIS
111. Mechanism Based Toolbox: Prototypical Implementation of Tools
112. Metabolic Response of Muscle to Trauma: Altered Control of Protein Turnover
113. Le test HPV urinaire proposé comme alternative au frottis cervico-utérin : étude pilote dans le département du Maine-et-Loire
114. A Pivotal Circulating Antibody Panel for Pre-Transplant Prediction of FSGS Recurrence After Kidney Transplantation.
115. NEW APPROACH FOR TESTING AND MODELLING OF FATIGUE BEHAVIOUR
116. Secondary resistances to measles virus (MeV)-based virotherapy
117. Building envelope: Performance optimisation processes for a daylight responsive architecture
118. The United Kingdom Childhood Cancer Study: objectives, materials and methods. UK Childhood Cancer Study Investigators
119. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway
120. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness
121. Seismic Loss Estimation Based on End-to-end Simulation
122. Charpy impact properties of pure tungsten plate material in as-received and recrystallized condition (1h at 2000°C (2273K))
123. MeV-RII_HepG2, a persistently measles virus (MeV) infected human hepatoma cell line, displays resistance towards secondary infections with MeV virotherapeutics
124. AB0204 Targeting of steady state DC via DEC205 and 33D1 expands regulatory T cells but does not restore tolerance in murine lupus
125. Experimental models of CKD
126. An All-Hazards Approach for Quantifying Loss of Function for Critical Healthcare Infrastructure
127. Gender and Racial Diversity in the Structural Engineering Profession
128. Incorporating Losses due to Repair Costs, Downtime and Fatalities in Performance-based Earthquake Engineering
129. Agent-Based Simulation of Building Evacuation after an Earthquake: Coupling Human Behavior with Structural Response.
130. Backcross breeding for improved resistance to common bacterial blight in pinto bean (Phaseolus vulgaris L. )
131. Crystal Structure of B. subtilis EngA in complex with GMPPCP
132. Crystal Structure of B. subtilis EngA in complex with sulfate ion and GDP
133. Crystal Structure of B. subtilis EngA in complex with half-occupacy GDP
134. Innate immune defence defines susceptibility of gastrointestinal and non-gastrointestinal sarcomas to measles vaccine virus based virotherapy
135. Expression of fgf23 and klotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio
136. Expected earthquake damage and repair costs in reinforced concrete frame buildings
137. Promouvoir la protection de l’audition des agents SNCF dont certains sont exposés au risque ferroviaire
138. Transplantation - basic
139. Glucose Effects on the Peritoneum: What Can We Learn from Rodent Models?
140. Rapid titration of retroviral vectors using a β-lactamase protein fragment complementation assay
141. Armed oncolytic measles vaccine virus–a novel therapeutic agent for virotherapy of sarcomas of gastrointestinal and non-gastrointestinal origin
142. Armed oncolytic measles vaccine virus – a novel therapeutic agent for virotherapy of solid tumors
143. Crystal Structure of MHC class I HLA-A2 molecule complexed with Human Prostaglandin Transporter decapeptide
144. Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide M5A variant
145. Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide V5M variant
146. Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide V6C variant
147. Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant
148. Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide
149. Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide N3S variant
150. Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide G4M-V5W variant
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.